clinical medical

What Has Stayed and What Disappeared In Benign Urology

“Any knowledge that doesn’t lead to new questions quickly dies out: it fails to maintain the temperature required for sustaining life,” said poet and Nobel Laureate Wislawa Szymborska.  Looking back at the past 50 years, I recounted the achievements and yet-to-be-conquered goals. It is also prudent to think back to what ideas/concepts have withstood the test of time, in the quest for knowledge and the inherent desire to replace old with new. Read more.

Source: Urology Times, June 16, 2022

An Effective Response to the Impact of Health Stigma Is Within Our Reach

We’re experiencing a renaissance of civil rights in this country. A woman has run for President of the United States on a major party ticket. People can marry whomever they choose. The country is caught up in a retelling of the story of our founding fathers – in a hip-hop musical written by a Latino and featuring a colorblind cast.

Major shifts indeed. And we plan to ignite yet another – for people of every age, gender, and life situation. For people who have difficulty walking, seeing, hearing, or comprehending the world around them, and millions more who cope with health conditions, seen and unseen, that redefine their life options. Disability and other health challenges have many causes – from accident, to disease, to genetic chance. The result is often a daily test of individual resolve and strength. But along with these solitary struggles, there is one common to all: stigma.Continue reading

When It Happens a Hundred Plus Times a Year, You Tend to Assume

One of my colleagues, a life coach, says if you are going to assume an outcome, then choose the assumption that makes you the happiest. It’s some of the best advice I’ve ever had…I fail miserably at it!

The problem is, when it happens a hundred plus times a year, my personal version of “stranger danger,” I tend to assume it is about to happen again whenever I am using crutches, sporting a visible difference in the form of a leg brace, and a stranger approaches.Continue reading

Central Street America

It’s funny what can bring you hope, sometimes it can be the simplest thing and yesterday it was, with the bonus of it happening on a picture perfect fall day.

Yes, Fall is finally here in the Midwest, the squirrels are crazy busy, school is back in session, and it is raining leaves! It’s once again that time of year when if you don’t have children to pick up after school you stay off the roads when the yellow buses swarm…stopping frequently (and holding up traffic) while their charges finally spill from the bus!

But sometimes household or work-related schedules must be met and even sans kids, you find yourself caught up in the after school mayhem. While it Continue reading

nurse and patient

COVID-19 Infection Increases the Risk of New or Worsening OAB Symptoms

Patients with COVID-19 infection are at increased risk of developing new or worsening symptoms of overactive bladder (OAB), according to data presented at the American Urological Association’s annual meeting in 2022 in New Orleans, Louisiana.  Ly Hoang Roberts, MD, of Oakland University, Royal Oak, Michigan, and colleagues noted that they were the first American group to identify de novo genitourinary symptoms, such as frequency, urgency, nocturia, and pain / pressure in people with previous COVID 19 infection. They called this condition COVID-19 associated cystitis (CAC).  Read more.

Source: Community 99, May 15, 2022

business buildings

First Quality Introduces MaxSorb+ Zone For Bladder Control Pads

First Quality Products, Inc. is launching a new technology for bladder control pads called MaxSorb+ Zone, providing enhanced rapid absorption to help keep skin dry all day and support skin health. Pads that use First Quality’s MaxSorb+ Zone absorb up to 50% faster compared to previous Prevail bladder control pads. Read more.

Source: Nonwovens Industry, April 28, 2022

operating room surgery

Simpler Surgery May Work As Well As Standard For Women With Incontinence

For women with frequent urine leakage, a newer and simpler “sling” surgery works as well as the standard version, according to a new clinical trial.  The study involved women with stress urinary incontinence, where movement that puts pressure on the abdomen — such as running, lifting, coughing or laughing — causes urine leakage. When the condition is severe, surgery may be recommended.  Read more.

Source: UPI, April 1, 2022

business buildings

Medtronic Kicks Off Pivotal Study of Tibial Neuromodulation Implant for Overactive Bladder

After receiving an FDA approval last month in bladder and bowel incontinence for its neuromodulation device implanted in the lower back, Medtronic isn’t resting on its laurels.  It has begun a clinical trial of a similar system placed near the ankle, which the company described as a more convenient option that may make the therapy available to more people. The medtech giant announced that its first patients have received implants in the pivotal study, with neurostimulators that tap into the posterior tibial nerve running up the back of the leg, to transmit electrical pulses that aim to help regulate an overactive bladder. Read more.

Source: Fierce Biotech, March 25, 2022

business buildings

Renovia, ObvioHealth Conclude Fully Virtual Medical Device Trial in Urogynaecology

Virtual Research Organisation (VRO) ObvioHealth may have completed the first ever fully virtual urogynaecology study, in the form of a medical device clinical trial of Renovia’s digital intravaginal device Leva for female stress urinary incontinence.  Urinary incontinence is unintentional passing of urine, which affects one in four women, particularly 75% of women above the age 65 reporting urine leakage. Pelvic floor muscle training (PMFT), commonly known as Kegels, is the standard among noninvasive approaches for urinary incontinence. However, 75% of women perform the exercises incorrectly by engaging wrong muscle groups or following a wrong routine. Leva is designed to help users how to preform Kegels more effectively. Read more.

Source: Clinical Trials Arena, March 17, 2022

business buildings

Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has approved its newly developed, long-lived, recharge-free sacral neuromodulation (SNM) implantable neurostimulator (INS).  Read more.

Source: Business Wire, March 7, 2022